Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6NCya-Ybx3em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6NCya-Ybx3em1/Cya

Common Name
Ybx3-KO
Product ID
S-KO-10830
Backgroud
C57BL/6NCya
Strain ID
KOCMP-56449-Ybx3-B6N-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Ybx3-KO Mouse (Catalog S-KO-10830) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Ybx3-KO
Strain ID
KOCMP-56449-Ybx3-B6N-VA
Gene Name
Ybx3
Product ID
S-KO-10830
Gene Alias
Yb2, Csda, Dpba, MSY3, MSY4, dbpA, oxyR
Background
C57BL/6NCya
Gene Full Name
Y box protein 3
Modification
Conventional knockout
NCBI ID
56449 (Mouse)
Phenotype
MGI:2137670
Chromosome
Chr 6 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000032309
NCBI Transcript ID
NM_139117
Target Region
Exon 2
Size of Effective Region
~1.7 kb
Overview of Gene Research
Ybx3, also known as DNA-binding protein-A, is a DNA/RNA binding protein belonging to the cold shock protein family. It is involved in multiple essential functions such as gene transcription, DNA repair, cell cycling, translation, and tight junction communication. It has been associated with pathways like PI3K/AKT, cell adhesion molecules, cAMP, calcium, focal adhesion, Ras, Rap1, NF-κB, and Chemokine signaling pathways, playing a crucial role in various biological processes and disease development [1,3]. Genetic models, especially gene knockout (KO) mouse models, have been valuable in studying Ybx3's functions.

In NPC, knockdown of YBX3 by lentivirus shRNA suppressed cell migration in vitro and metastasis in vivo, with YBX3 regulating NPC metastasis through the PI3K/AKT signaling pathway [1]. In BAT, both in vitro loss-and gain-of-function experiments demonstrated YBX3 is essential for brown adipocyte differentiation and thermogenesis. BAT-specific loss of Ybx3 in mice dampened thermogenesis and exacerbated diet-induced obesity [2]. In kidney IRI, genetic deletion of Ybx3 in mice protected from IRI with less immune cell infiltration, endoplasmic reticulum stress and tubular cell damage, by upregulating antioxidant activities and reducing ferroptosis [3]. In BLCa, BLACAT3 recruits YBX3 to shuttle into the nucleus promoting angiogenesis and hematogenous metastasis [4]. In MSCs, circSERPINE2 sequesters YBX3 in the cytoplasm, affecting p21 ubiquitin-mediated degradation and MSC senescence [5]. In ccRCC, high expression of YBX3 was correlated with tumor progression and poor prognosis, and in vitro silencing of YBX3 affected cell proliferation, migration, etc. [6]. In skeletal muscle cells, depletion of YBX3 reduced proliferation and impaired differentiation [7].

In conclusion, Ybx3 plays diverse and significant roles in multiple biological processes and disease conditions. Studies using KO/CKO mouse models have revealed its importance in cancer metastasis (NPC, BLCa, ccRCC), metabolic regulation (BAT thermogenesis), and organ injury protection (kidney IRI), as well as in cell-specific functions like MSC senescence and skeletal muscle cell proliferation and differentiation. Understanding Ybx3's functions through these model-based research provides insights into disease mechanisms and potential therapeutic targets.

References:
1. Fan, Xiaoqin, Xie, Xina, Yang, Ming, Wen, Weiping, Nie, Guohui. 2021. YBX3 Mediates the Metastasis of Nasopharyngeal Carcinoma via PI3K/AKT Signaling. In Frontiers in oncology, 11, 617621. doi:10.3389/fonc.2021.617621. https://pubmed.ncbi.nlm.nih.gov/33816248/
2. Chen, Lin-Yun, Wang, Li-Wen, Wen, Jie, Luo, Xiang-Hang, Feng, Xu. 2024. RNA-binding protein YBX3 promotes PPARγ-SLC3A2 mediated BCAA metabolism fueling brown adipogenesis and thermogenesis. In Molecular metabolism, 90, 102053. doi:10.1016/j.molmet.2024.102053. https://pubmed.ncbi.nlm.nih.gov/39481849/
3. Reichardt, Charlotte, Brandt, Sabine, Bernhardt, Anja, Isermann, Berend, Mertens, Peter R. 2024. DNA-binding protein-A promotes kidney ischemia/reperfusion injury and participates in mitochondrial function. In Kidney international, 106, 241-257. doi:10.1016/j.kint.2024.05.009. https://pubmed.ncbi.nlm.nih.gov/38821446/
4. Xie, Jinbo, Zhang, Hui, Wang, Keyi, Mao, Weipu, Peng, Bo. 2023. M6A-mediated-upregulation of lncRNA BLACAT3 promotes bladder cancer angiogenesis and hematogenous metastasis through YBX3 nuclear shuttling and enhancing NCF2 transcription. In Oncogene, 42, 2956-2970. doi:10.1038/s41388-023-02814-3. https://pubmed.ncbi.nlm.nih.gov/37612524/
5. Chen, Fenglei, Wang, Shan, Zeng, Chenying, Wu, Yanfeng, Shen, Huiyong. 2023. Silencing circSERPINE2 restrains mesenchymal stem cell senescence via the YBX3/PCNA/p21 axis. In Cellular and molecular life sciences : CMLS, 80, 325. doi:10.1007/s00018-023-04975-6. https://pubmed.ncbi.nlm.nih.gov/37831180/
6. Wang, Chen, You, Zhijie, He, Yihui, Chen, Xin. 2023. Identification of RNA-binding protein YBX3 as an oncogene in clear cell renal cell carcinoma. In Functional & integrative genomics, 23, 225. doi:10.1007/s10142-023-01145-6. https://pubmed.ncbi.nlm.nih.gov/37418046/
7. Awad, Silina, Skipper, William, Vostrejs, William, Mehta, Darshan, Cooke, Amy. 2023. The YBX3 RNA-binding protein posttranscriptionally controls SLC1A5 mRNA in proliferating and differentiating skeletal muscle cells. In The Journal of biological chemistry, 300, 105602. doi:10.1016/j.jbc.2023.105602. https://pubmed.ncbi.nlm.nih.gov/38159852/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research